[Form 4] Viavi Solutions Inc. Insider Trading Activity

Rhea-AI Filing Summary

Viavi Solutions (VIAV) insider transaction: Paul McNab, EVP, Chief Marketing & Strategy Officer and director, reported a disposition of 3,065 shares on 09/09/2025 via an exempt transaction, at $0 reported price (not applicable). After the transaction he beneficially owns 51,646 shares. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.

Positive

• None.

Negative

• Disposition of 3,065 shares by a senior executive was reported, reducing the reporting person's holdings from approximately 54,711 to 51,646 shares.
• No price or proceeds disclosed (price shown as $0 and noted as not applicable), limiting transparency about the economic terms of the transaction.

Insights

Financial Analyst

TL;DR: Insider sale of a small portion of holdings; no additional context on reason or price provided.

The filing shows an exempt disposition of 3,065 shares by a senior executive who remains a meaningful shareholder with 51,646 shares after the sale. Because the reported price is indicated as $0 and the transaction is labeled exempt, the Form 4 lacks pricing or proceeds detail, limiting assessment of timing or tax/plan-driven motives. On its face this is a routine insider share transfer rather than a disclosed open-market sale.

Corporate Governance Expert

TL;DR: Routine reporting compliance for an officer/director; transaction appears non-economically informative.

The report fulfills Section 16 reporting requirements for an officer who is also a director. The use of an exempt transaction code and an attorney-in-fact signature are typical in administrative transfers or plan-related movements. Without commentary on the exemption type or supporting documentation, the filing does not signal a governance concern but also provides limited insight into intent.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McNab Paul

(Last) (First) (Middle)

C/O VIAVI SOLUTIONS INC.

1445 SOUTH SPECTRUM BLVD, SUITE 102

(Street)

CHANDLER AZ 85286

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VIAVI SOLUTIONS INC. [ VIAV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Mktg & Stgy Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/09/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/09/2025		G		3,065(1)	D	$0(2)	51,646	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares that were transferred pursuant to an exempt transaction.

2. Not applicable.

	/s/ Donna T. Rossi, attorney-in-fact	09/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Paul McNab report on the Form 4 for VIAV?

He reported an exempt disposition of 3,065 shares on 09/09/2025, leaving him with 51,646 shares beneficially owned.

What is the reporting person’s role at Viavi (VIAV)?

The filing lists Paul McNab as a Director and EVP, Chief Marketing & Strategy Officer.

Was a sale price disclosed on the Form 4?

No; the Form 4 shows a price of $0 and notes that price is not applicable, indicating an exempt transfer without economic terms reported.

When was the Form 4 signed and by whom?

The form was signed on 09/09/2025 by Donna T. Rossi as attorney-in-fact for the reporting person.

Does the Form 4 indicate this was part of a trading plan?

The filing does not state that the transaction was made pursuant to a Rule 10b5-1 trading plan; no plan reference is provided in the content.